Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Part IV
DEVELOPING, IMPLEMENTING, AND EVALUATING POPULATION INTERVENTIONS

Figure 1

The likelihood of developing overt hemochromatosis is shown as a function of HFE genotype in this horizontal bar chart. C282Y homozygotes have the highest risk, with risk declining progressively for compound heterozygotes (C282Y/H63D), H63D homozygotes, and C282Y heterozgotes. H63D heterozygotes are assumed to have the same minimal degree of risk as persons without identifiable mutations; in this category, the risk reflects the small possibility of carrying mutations not currently identifiable.  For all genotypes, the risk of disease increases or decreases according to the presence of modifying factors such as gender, alcohol use and iron intake.


 

Contact Us:
  • CDC-INFO Contact Center
    Phone: 800-232-4636 (800-CDC-INFO)

    Hearing Impaired: 888-232-6348
  • cdcinfo@cdc.gov
  • Additional information for Public Health Genomics is available on our contact page.
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #